Cutting Edge Thoughts on Drug Regulation by Matt Zorn
Lawyer
The number of free subscribers for On Drugs over time since it was added to the directory.
Irreverent commentary on Cannabis industry business, law, and capital markets since 2018 (ask me about older posts!).
An independent journalism newsletter supported by the U.C. Berkeley Center for the Science of Psychedelics
on the business, policy and science of psychedelics